Literature DB >> 9391524

The use of in bowel urology. Metabolic and nutritional complications.

D S Stampfer1, W S McDougal, F J McGovern.   

Abstract

Metabolic and nutritional complications of urinary diversion through bowel or stomach segments are common, but fortunately, not often severe. When metabolic abnormalities are problematic, deterioration or baseline insufficiency in renal function is the most likely cause. Deterioration is most commonly associated with obstruction or infection. The urologist should be acutely aware of the potential for metabolic derangements when the prediversion creatinine is greater than 2.0 mg/dL. In this situation, the urologist should employ the basic principles in this article when planning the procedure in order to minimize metabolic complications and morbidities. In the setting of significant renal insufficiency, a short colon or ileal conduit would likely be superior to an ileal or colonic neobladder, or a diversion, incorporating a large gastric segment. Furthermore, in the absence of symptomatic metabolic abnormalities, we advocate treatment of minor laboratory abnormalities, particularly acidosis, to reduce the incidence of metabolic bone disease. Nutritional and gastrointestinal complications are treated on an "as needed" basis, with the exception of metabolic bone disease, which we would hope to prevent with alkalinization and Vitamin C supplementation. Some of the nutritional and gastrointestinal complications are best avoided by leaving the ileocecal valve intact, or by minimizing the use of certain segments. Some evidence exists that over time, histologic changes in the epithelium of diversion segments may impair absorption and contribute to greater resistance against metabolic derangements. Whether the changes truly reduce the incidence of metabolic abnormalities remains to be studied. The ideal, complication-free, diversion with universal application does not exist; however, the urologist must strive to select an option that will provide a functional result for the patient with minimal associated morbidity.

Entities:  

Mesh:

Year:  1997        PMID: 9391524     DOI: 10.1016/s0094-0143(05)70413-4

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  8 in total

Review 1.  [Alkaline citrates in urology. A status report].

Authors:  L Rinnab; R E Hautmann; M Straub
Journal:  Urologe A       Date:  2004-04       Impact factor: 0.639

2.  The Studer orthotopic neobladder: long-term (more than 10 years) functional outcomes, urodynamic features, and complications.

Authors:  Jong Kil Nam; Tae Nam Kim; Sung Woo Park; Sang Don Lee; Moon Kee Chung
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

3.  Metabolic changes and urodynamic findings after continent urinary diversion.

Authors:  D Weckermann; F Wawroschek; J Schipp; G Krawczak; R Harzmann
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

4.  [Avoidance and management of complications in open surgical ureter reconstruction].

Authors:  D A Lazica; A S Brandt; S Roth
Journal:  Urologe A       Date:  2014-07       Impact factor: 0.639

5.  Our experience with ureterocystoplasty in bilateral functional kidneys.

Authors:  Giray Ergin; Burak Köprü; Turgay Ebiloğlu; Yusuf Kibar; Murat Dayanç
Journal:  Turk J Urol       Date:  2018-08-17

Review 6.  Advances in bladder augmentation.

Authors:  Erica L Schalow; Andrew J Kirsch
Journal:  Curr Urol Rep       Date:  2002-04       Impact factor: 2.862

7.  Santosh PGI pouch: A new innovation in urinary diversion.

Authors:  Santosh Kumar; Sudheer Kumar Devana; Aditya Prakash Sharma; Shrawan Kumar Singh
Journal:  Cent European J Urol       Date:  2015-06-18

Review 8.  The evolution of bladder augmentation: from creating a reservoir to reconstituting an organ.

Authors:  Roman Jednak
Journal:  Front Pediatr       Date:  2014-02-10       Impact factor: 3.418

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.